nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma
|
Park, Steven I. |
|
|
4 |
11 |
p. 2548-2555 |
artikel |
2 |
Apolipoprotein A-I enhances activated protein C cytoprotective activity
|
Gleeson, Eimear M. |
|
|
4 |
11 |
p. 2404-2408 |
artikel |
3 |
Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma
|
Iyer, Aishwarya |
|
|
4 |
11 |
p. 2489-2500 |
artikel |
4 |
Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry)
|
Mirza, Reza |
|
|
4 |
11 |
p. 2460-2467 |
artikel |
5 |
Diagnosis of deep vein thrombosis of the upper extremity: a systematic review and meta-analysis of test accuracy
|
Patel, Payal |
|
|
4 |
11 |
p. 2516-2522 |
artikel |
6 |
Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation
|
Inamoto, Yoshihiro |
|
|
4 |
11 |
p. 2409-2417 |
artikel |
7 |
Editorial Board
|
|
|
|
4 |
11 |
p. i |
artikel |
8 |
Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG mice
|
Lysenko, Veronika |
|
|
4 |
11 |
p. 2477-2488 |
artikel |
9 |
Gene expression profiling of gray zone lymphoma
|
Sarkozy, Clémentine |
|
|
4 |
11 |
p. 2523-2535 |
artikel |
10 |
High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential
|
Busque, Lambert |
|
|
4 |
11 |
p. 2430-2438 |
artikel |
11 |
Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient
|
Oza, Aabha |
|
|
4 |
11 |
p. 2387-2391 |
artikel |
12 |
Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo
|
Thamilarasan, Madhan |
|
|
4 |
11 |
p. 2372-2386 |
artikel |
13 |
Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma
|
Ottolini, Barbara |
|
|
4 |
11 |
p. 2392-2403 |
artikel |
14 |
New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT
|
Elfeky, Reem |
|
|
4 |
11 |
p. 2418-2429 |
artikel |
15 |
Novel mouse model resistant to irreversible BTK inhibitors: a tool identifying new therapeutic targets and side effects
|
Estupiñán, H. Yesid |
|
|
4 |
11 |
p. 2439-2450 |
artikel |
16 |
Outcomes associated with apixaban vs warfarin in patients with renal dysfunction
|
Hanni, Claudia |
|
|
4 |
11 |
p. 2366-2371 |
artikel |
17 |
Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort
|
Schoettler, Michelle |
|
|
4 |
11 |
p. 2536-2547 |
artikel |
18 |
Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosis
|
Fronas, Synne G. |
|
|
4 |
11 |
p. 2468-2476 |
artikel |
19 |
The great platelet paradox: evolution of platelet contribution to hemostasis, inflammation, and thrombosis after injury
|
Neal, Matthew D. |
|
|
4 |
11 |
p. 2556 |
artikel |
20 |
Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease
|
Boucault, Laetitia |
|
|
4 |
11 |
p. 2501-2515 |
artikel |
21 |
Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study
|
Warren, Beth Boulden |
|
|
4 |
11 |
p. 2451-2459 |
artikel |